Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Share, 2019, Global Industry Growth, Trends, Merger, Analysis, Competitive Landscape, Key Players And Regional Forecast To 2027
Age-related macular degeneration (AMD) is a visual impairment disorder in the aged population, which is an acquired retinal disorder and leads to the deterioration of the macula. This disorder might cause vision loss mainly in people age 60 years or above. In the early stage, AMD might not show any symptoms, but the symptoms can be seen while the disease progresses include dark spots or degeneration in central vision and blurred vision. Obesity, smoking, high cholesterol, UV radiation, high blood pressure, genetic factors, poor diet, and light eye color are some of the symptom of age-related macular degeneration.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/786
The growing prevalence rate of AMD is propelling the growth of age-related macular degeneration market
According to World Health Organization (WHO), age-related macular degeneration has 3rd rank in the global cause of visual impairment with 8.7% blindness prevalence, whereas, Community Eye Health Journal, by London School of Hygiene and Tropical Medicine, in 2014, around 196 million people will suffer from AMD by 2020 globally. The advent of advanced technologies in the healthcare sector and the upgraded diagnostic facility is projected to foster the growth of age-related macular degeneration market.
On the flip side, the high cost of the treatment, growing off –label use and stringent regulatory policies are expected to hamper the market growth. For instance, a single injection of anti-vascular endothelial growth factor (anti-VEGF) agents for the treatment of AMD such as ranibizumab cost about $2000. The growing geriatric population base rate and rising awareness of AMD are projected to offer more opportunities in age-related macular degeneration market.
The growing prevalence rate of dry age-related macular degeneration is accounting for the major share contribution of this segment in the age-related macular degeneration
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/786
The global age-related macular degeneration market is segmented by type and by the drug.
Based on type, the age-related macular degeneration market is segmented into
- Dry age-related macular degeneration
- Wet age-related macular degeneration
Based on the drug, the age-related macular degeneration market is segmented into
The rapid growth of the geriatric population is boosting the growth of age-related macular degeneration market in North America
Regional segmentation of age-related macular degeneration market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. North America dominating the overall market and this can be attributed to the growing geriatric population and the growth in demand for the treatment of age-related macular degeneration in the region. For instance, the data published by UN publication in “World Population Ageing 2013”, around 70,571,000 people were of 60 years and above in North America in 2013, that is, 19.9% of the total population of the region. Moreover, the rising prevalence of age-related macular degeneration (AMD), growing awareness of AMD, and the high rate of drug treatment are also fuelling the growth of age-related macular degeneration market in North America. Besides o this, Asia Pacific is also projected to experience growth in the age-related macular degeneration market owing to the growth of the geriatric population, resulting in the occurrence of AMD.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/age-related-macular-degeneration-market-786
Fast track designations for drugs in the treatment of AMD is helping the new players to sustain in the age-related macular degeneration market
Key industry players operating the age-related macular degeneration market include Novartis AG, Bayer AG, Acucela, Neurotech Pharmaceuticals Inc., Hoffmann-La Roche Limited, Ophthotech Co., GlaxoSmithKline Plc., Alimera Sciences Inc., StemCell Inc., and Regeneron Pharmaceutical Inc. An increasing number of pipeline drugs for age-related macular degeneration is offering the players new growth opportunities to sustain in the age-related macular degeneration market. Moreover, fast track drug designations and special regulator government policies such as tax benefits are some other factors helping the new players to enter in the age-related macular degeneration market. For instance, Fovista a product of Ophthotech received fast track designation by U.S. FDA and is expected to launch in 2018.
Table of Content
Global Age-related Macular Degeneration (AMD) Therapeutics Market Research Report
Section 1: Global Age-related Macular Degeneration (AMD) Therapeutics Industry Overview
Section 2: Global Economic Impact on Age-related Macular Degeneration (AMD) Therapeutics Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Age-related Macular Degeneration (AMD) Therapeutics Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Age-related Macular Degeneration (AMD) Therapeutics Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire